Stealthyx Therapeutics Ltd.

Stealth BioTherapeutics Inc. faces an uphill climb at a 10 October advisory committee meeting given the US Food and Drug Administration staff’s view that the available evidence does not establish ela

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

IN VITRO DIAGNOSTICS CardioDx Inc. CardioDx closes $35mm late-stage round CardioDx Inc. (cardiovascular diagnostics) raised $35mm in a late-stage financing from Alberta Investment Management a